Current situation of women in Urology in Colombia

Current situation of women in Urology in Colombia

by
There are 61 (9%) feminine urologist enrolled at Sociedad Colombiana de Urología. 41 (40%) of urology residentes in Colombia are ladies. The purpose of this examine is to exhibit the work tendencies of feminine urologist, feminine residents and affected person’s preferences relating to the gender of their urologist. MATERIALS AND METHODS: Descriptive observational sectional examine with nameless surveys carried out to working towards feminine urologists, feminine residents, and sufferers.
The questions evaluated the demographic traits of the surveyed people; the questions for feminine urologists evaluated their work tendencies; for the residents we evaluated their plans as urologists; and the sufferers have been requested about their preferences to be evaluated in medical session and to have a surgical procedure carried out by both a male or feminine urologist. RESULTS: The survey was answered by 53 feminine urologists.
The common age was 37 years, the bulk (54%) labored in Bogotá. 34% have subspecialized, the bulk in andrology (16%) endourology (16%) and pediatric urology (16%). Most of them (73.6%) carry out surgical procedure between 5-20 hours weekly, and essentially the most carried out surgical procedure was varicocelectomy. 34% referred to have been harassed of their work surroundings based mostly on their gender.Thirty-six feminine residents answered the survey. Th eaverage age was 28 years.
The common variety of tutorial publications was 3. 80% want to obtain a sub-specialization, of which 24% would do it in endourology. 41% referred to have been harassed. 188 sufferers answered the survey, 96 males and 87 ladies; 44.1% most well-liked to be attended in medical session by a feminine urologist, and 49.2% most well-liked to be operated by a male urologist. CONCLUSIONS: The variety of feminine urologists has exponentially elevated, simply as the share of feminine residents. Feminine residents want to subspecialize in various areas. Sufferers desire to be attended by a feminine urologist in medical session however desire to have surgical procedure carried out by a male urologist.

Microbiome research in urology– the place will we stand and the place can we attain?

The position of microbiome milieu within the urinary tract, their interaction in various urological circumstances and their therapeutic implications should not utterly understood. The microbiome has contributed in the direction of urinary tract infections, urolithiasis and urological cancers. The potential of manipulating microbiome for prognosis and remedy is evolving. Probiotics would possibly assist in overcoming the issues of recurrent an infection and antibiotic resistance.
Novel purposes like stents and catheters coated with non-pathogenic organisms are being developed. Analysis within the urinary microbiome has progressed from utilizing mouse fashions to the presently out there three- dimensional cultured organoids, thus making it extra possible. As our information relating to the urinary microbiome will increase, justice might be carried out to many sufferers in whom the developments can be utilized for prophylaxis, prognosis, remedy and even in enhancing their high quality of life.
The rising quantity of antibiotic resistance can be a matter of concern and probiotics is perhaps the reply to this upcoming calamity. On this assessment, we’ve mentioned the position of the urinary microbiome in pathogenesis, prognosis and remedy of urological circumstances and contemplated upon its future prospects.
Current situation of women in Urology in Colombia

Way of life in urology: Benign illnesses

Modifiable lifestyle-related threat elements are the thing of accelerating consideration, with a view to main and tertiary prevention, to restrict the onset and improvement of illnesses.Additionally within the urological area there may be accumulating proof of the connection between urological illnesses and lifestyle-related threat elements that may affect their incidence and prognosis.
Danger elements resembling diet, bodily exercise, sexual habits, tobacco smoking, or alcohol consumption might be modified to restrict morbidity and scale back the social impression and the burdensome prices related to prognosis and remedy.
This assessment synthesizes the present scientific proof out there on this subject, attempting to fulfill the necessity for a abstract on the relationships between crucial way of life elements and the primary benign urological illnesses, specializing in benign prostatic hyperplasia (BPH), infections urinary tract (UTI), urinary incontinence (UI), stones, erectile dysfunction, and male infertility.

COVID-19 in european urology : Which classes have we realized?

The coronavirus has challenged all medical methods worldwide. Herein each waves of COVID-19 (coronavirus illness 2019) in spring and autumn 2020 differ principally. Whereas Europe was hit by the primary wave roughly unprepared, which was aggravated by the excessive virulence of COVID-19, the second wave is characterised by a a lot larger contagiosity of the virus with very excessive incidences.
However the virus has attenuated, which is mirrored by the considerably decrease incidence-related mortality fee. Nonetheless, the general rising variety of contaminated sufferers represents once more an important problem for the medical administration of the illness. France and Spain are doing higher compared to Germany and Italy this time.
Absolutely the variety of deaths per week is larger than throughout the peak of the primary wave. Nonetheless, urologists in these nations have additionally skilled better restrictions of their actions within the second shutdown than in Germany, the place there may be solely a discount of beds to between 75 and 90%.
Largely all ranges are operated. Of significance for Germany, nevertheless, is the plateau on a excessive degree for a number of weeks most likely because of the decreased efficacy of a lightweight lock-down. This lastly resulted in a complete lock-down in mid-December 2020. Subsequently in Germany some hospitals are additionally reaching their limits with related penalties for the departments of urology going through a 50% discount of beds and working solely degree III and IV indications.

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-b-48Tests 48 Tests
EUR 555

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-b-96Tests 96 Tests
EUR 771

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-c-48Tests 48 Tests
EUR 533

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-c-96Tests 96 Tests
EUR 740

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-Hu-48Tests 48 Tests
EUR 367

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-Hu-96Tests 96 Tests
EUR 502

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-p-48Tests 48 Tests
EUR 555

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-p-96Tests 96 Tests
EUR 771

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-Ra-48Tests 48 Tests
EUR 511

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
RD-LIF-Ra-96Tests 96 Tests
EUR 709

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-b-48T 48T
EUR 547
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-b-96T 96T
EUR 715
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-c-48T 48T
EUR 527
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-c-96T 96T
EUR 688
Description: A sandwich quantitative ELISA assay kit for detection of Canine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-Hu-48T 48T
EUR 380
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-Hu-96T 96T
EUR 485
Description: A sandwich quantitative ELISA assay kit for detection of Human Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-p-48T 48T
EUR 547
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-p-96T 96T
EUR 715
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-Ra-48T 48T
EUR 508
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
DLR-LIF-Ra-96T 96T
EUR 661
Description: A sandwich quantitative ELISA assay kit for detection of Rat Leukemia Inhibitory Factor (LIF) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-b-48Tests 48 Tests
EUR 580

Bovine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-b-96Tests 96 Tests
EUR 807

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-c-48Tests 48 Tests
EUR 557

Canine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-c-96Tests 96 Tests
EUR 774

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-Hu-48Tests 48 Tests
EUR 383

Human Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-Hu-96Tests 96 Tests
EUR 525

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-p-48Tests 48 Tests
EUR 580

Porcine Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-p-96Tests 96 Tests
EUR 807

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-Ra-48Tests 48 Tests
EUR 534

Rat Leukemia Inhibitory Factor (LIF) ELISA Kit
RDR-LIF-Ra-96Tests 96 Tests
EUR 742

Anti-LIF Antibody
PA1562 100ug/vial
EUR 294

Anti-LIF Antibody
PB9036 100ug/vial
EUR 334

Anti-LIF antibody
STJ29846 100 µl
EUR 277
Description: The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.

Anti-LIF Antibody
A01400 100ug/vial
EUR 294

Anti-LIF antibody
STJ96472 200 µl
EUR 197
Description: Rabbit polyclonal to LIF.

Anti-LIF antibody
STJ73631 100 µg
EUR 359

anti- LIF antibody
FNab09804 100µg
EUR 548.75
Description: Antibody raised against LIF

anti- LIF antibody
LSMab09804 100 ug
EUR 386

LIF, Mouse
HY-P7084 50ug
EUR 533

LIF, mouse
MO16102 100 ug
EUR 675

Anti-LIF (aa28-39) antibody
STJ72919 100 µg
EUR 359

Polyclonal Goat anti-GST α-form
GST-ANTI-1 50 uL
EUR 280

Polyclonal Goat anti-GST μ-form
GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form
GST-ANTI-3 50 uL
EUR 280

Recombinant Mouse LIF Protein
R01400-1 100ug/vial
EUR 294

Mouse LIF ELISA Kit
EML0014 96Tests
EUR 521

Mouse LIF shRNA Plasmid
20-abx971321
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

LIF Antibody
1-CSB-PA198481
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100

LIF Antibody
1-CSB-PA012928ESR2HU
  • EUR 222.00
  • EUR 335.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA

LIF Antibody
1-CSB-PA004761
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

LIF, Human
HY-P7049 10ug
EUR 1600

LIF, human
MO16101 100 ug
EUR 688

LIF Antibody
36950-100ul 100ul
EUR 252

LIF Antibody
25283-100ul 100ul
EUR 390

LIF siRNA
20-abx922546
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

LIF siRNA
20-abx922547
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

rHu LIF
AK9977-0005 5µg Ask for price

rHu LIF
AK9977-0025 25µg Ask for price

rHu LIF
AK9977-0100 100µg Ask for price

rHu LIF
AK9977-1000 1mg Ask for price

LIF Peptide
6245P 0.05 mg
EUR 164.75
Description: (IN) LIF peptide

LIF Peptide
43-200P 0.1 mg
EUR 338

LIF antibody
70R-12299 100 ug
EUR 403
Description: Rabbit polyclonal LIF antibody

LIF antibody
70R-14100 100 ug
EUR 322
Description: Affinity purified Rabbit polyclonal LIF antibody

LIF antibody
70R-6230 50 ug
EUR 467
Description: Rabbit polyclonal LIF antibody

LIF antibody
70R-51295 100 ul
EUR 244
Description: Purified Polyclonal LIF antibody

LIF protein
30R-2771 10 ug
EUR 369
Description: Purified recombinant Human LIF protein

LIF protein
30R-2772 10 ug
EUR 489
Description: Purified recombinant Mouse LIF protein

LIF Antibody
6245-002mg 0.02 mg
EUR 171.82
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation.

LIF Antibody
6245-01mg 0.1 mg
EUR 436.42
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation.

LIF antibody
PAab09804 100 ug
EUR 386

LIF Antibody
5216-100
EUR 316

LIF Antibody
5216-30T
EUR 146

LIF Antibody
DF13730 100ul
EUR 350

Mouse LIF PicoKine ELISA Kit
EK0580 96 wells
EUR 425
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA).

Leukemia Inhibitory Factor (LIF), mouse
PR16102 5 ug
EUR 435

LIF, Mouse Recombinant , 1MIU/ml
L4500-001 1ml
EUR 339

LIF, Mouse Recombinant , 1MIU/ml
L4500-005 5x1ml
EUR 1193

LIF, Mouse Recombinant , 10MIU/ml
L4501-001 1ml
EUR 1454

LIF ELISA Kit (Mouse) (OKEH04045)
OKEH04045 96 Wells
EUR 544
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL

LIF ELISA Kit (Mouse) (OKBB00760)
OKBB00760 96 Wells
EUR 505
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml

ELISA kit for Mouse LIF
EK5250 96 tests
EUR 553
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse LIF in samples from serum, plasma, tissue homogenates and other biological fluids.

Lif ORF Vector (Mouse) (pORF)
ORF049145 1.0 ug DNA
EUR 506

Lif ORF Vector (Mouse) (pORF)
ORF049146 1.0 ug DNA
EUR 506

Human CellExp? LIF, mouse recombinant
7268-10
EUR 370

LIF Polyclonal Antibody
ES3837-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

LIF Polyclonal Antibody
ES3837-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against LIF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Polyclonal LIF Antibody
APR00279G 0.1mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications:

Polyclonal LIF Antibody
APR06696G 0.1 mg
EUR 659
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF . This antibody is tested and proven to work in the following applications:

LIF Polyclonal Antibody
ABP52838-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF

LIF Polyclonal Antibody
ABP52838-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF

LIF Polyclonal Antibody
ABP52838-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of LIF from Human. This LIF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human LIF

LIF Blocking Peptide
20-abx064170
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg

LIF Rabbit pAb
A1288-100ul 100 ul
EUR 308

LIF Rabbit pAb
A1288-200ul 200 ul
EUR 459

LIF Rabbit pAb
A1288-20ul 20 ul
EUR 183

LIF Rabbit pAb
A1288-50ul 50 ul
EUR 223

LIF Conjugated Antibody
C36950 100ul
EUR 397

LIF Polyclonal Antibody
41551-100ul 100ul
EUR 252

LIF Polyclonal Antibody
41551-50ul 50ul
EUR 187

LIF Blocking Peptide
33R-4712 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LIF antibody, catalog no. 70R-6230

LIF Recombinant Protein
40-682 5 ug
EUR 259.25
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Murine LIF is a 19.9 kDa protein containing 180 amino acids residues, including three disulfide bonds.

LIF Recombinant Protein
40-684 5 ug
EUR 259.25
Description: LIF is a pleiotrophic factor produced by multiple cell types, including T cells, myelomonocytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant Human LIF is a 19.7 kDa protein containing 180 amino acid residues, including three disulfide bonds.

LIF Recombinant Protein
97-011 0.02 mg
EUR 390.5
Description: Leukemia inhibitory factor, or LIF, an interleukin 6 class cytokine, is a protein in cells that affects cell growth and development.Leukemia Inhibitory Factor has several functions such as cholinergic neuron differentiation, control of stem cell pluripotency, bone & fat metabolism, mitogenesis of factor dependent cell lines & promotion of megakaryocyte production in vivo. Removal of LIF pushes stem cells toward differentiation, but they retain their proliferative potential or pluripotency. Therefore LIF is used in mouse embryonic stem cell culture. It is necessary to maintain the stem cells in an undifferentiated state, however genetic manipulation of embryonic stem cells allows for LIF independent growth, notably overexpression of the gene Nanog. LIF is not required for culture of human embryonic stem cells.

LIF, human recombinant
4923-10
EUR 305

LIF, human recombinant
4923-1000
EUR 5705

LIF, human recombinant
4923-50
EUR 664

LIF, murine recombinant
4924-10
EUR 370

LIF, murine recombinant
4924-1000
EUR 6836

LIF Recombinant Protein
90-277 10 ug
EUR 338
Description: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities also include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation and the stimulation of acute-phase protein synthesis in hepatocytes. LIF activates JAK & STAT signaling in human embryonic stem (ES) cells, but this pathway does not maintain pluripotency in these cells, which instead rely on FGF2-mediated ERK signaling. By contrast, mouse ES cells can be maintained by LIF-mediated JAK & STAT signaling. LIF binds to a high affinity heterodimeric receptor complex consisting of two proteins: LIF-R alpha that binds LIF with low affinity and the 130kDa (gp130) subunit that by itself does not bind LIF, but is required for high affinity binding of LIF.

LIF Recombinant Protein
91-014 0.05 mg
EUR 542.75
Description: Leukemia Inhibitory Factor (LIF) is a lymphoid factor that promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. LIF has a number of other activities including cholinergic neuron differentiation, control of stem cell pluripotency, bone and fat metabolism, mitogenesis of certain factor dependent cell lines and promotion of megakaryocyte production in vivo. Human and murine mature LIF exhibit a 78% sequence identity at the amino acid level. Human LIF is equally active on human and mouse cells. Murine LIF is approximately 1000 fold less active on human cells than human LIF.

LIF Recombinant Protein
91-575 0.05 mg
EUR 490.25
Description: Mouse Leukemia inhibitory factor（lif）is a secreted protein which belongs to the LIF/OSM family.LIF has been implicated in a many physiological processes including development, hematopoiesis, bone metabolism, and inflammation. it has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.

LIF, Leukemia inhibitory factor, murine (mouse)
RC234-18 5ug
EUR 104.38

Mouse Leukemia Inhibitory Factor (LIF) Protein
20-abx067761
  • EUR 662.00
  • EUR 272.00
  • EUR 2012.00
  • EUR 787.00
  • EUR 481.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Leukemia Inhibitory Factor (LIF) Protein
abx262959-1mg 1 mg
EUR 3168

Mouse Leukemia Inhibitory Factor (LIF) Protein
abx262959-3x10g 3x10 µg
EUR 328

Mouse Leukemia Inhibitory Factor (LIF) Protein
abx262959-3x2g 3x2 µg
EUR 230

Recombinant Mouse Leukemia Inhibitory Factor/lIF
C690-10ug 10ug
EUR 146
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse Leukemia Inhibitory Factor/lIF
C690-1mg 1mg
EUR 2283
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse Leukemia Inhibitory Factor/lIF
C690-500ug 500ug
EUR 1613
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse Leukemia Inhibitory Factor/lIF
C690-50ug 50ug
EUR 303
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Lif sgRNA CRISPR Lentivector set (Mouse)
K3872501 3 x 1.0 ug
EUR 339

Nori® Mouse LIF ELISA Kit
GR117058 96-well
EUR 461

Recombinant Human LIF Protein
RP00089 10 μg
EUR 174

Sheep LIF ELISA Kit
ESL0014 96Tests
EUR 521

Recombinant Human LIF Protein
PROTP15018-5 25ug
EUR 317
Description: LIF is a pleiotrophic factor produced by multiple cell types including T cells, myelomoncytic lineages, fibroblasts, liver, heart and melanoma. LIF promotes long-term maintenance of embryonic stem cells by suppressing spontaneous differentiation. Other activities include the stimulation of acute phase protein synthesis by hepatocytes, stimulation of differentiation of cholinergic nerves, and suppression of adipogenesis by inhibiting the lipoprotein lipase in adipocytes. While human LIF is active on mouse cells and is widely used in the maintenance of murine ESC to prevent spontaneous differentiation, mouse LIF is not active on human cells due to its inability to bind to the human LIF receptor. Recombinant human LIF is a 19.6 kDa protein containing 180 amino acids residues including three disulfide bonds.

LIF/Leukemia inhibitory factor
E21-017 10ug
EUR 343

LIF/Leukemia inhibitory factor
E21-690 10ug
EUR 343

Anserini LIF ELISA Kit
EAL0014 96Tests
EUR 521

Rat LIF ELISA Kit
ERL0014 96Tests
EUR 521

Rabbit LIF ELISA Kit
ERTL0014 96Tests
EUR 521

Monkey LIF ELISA Kit
EMKL0014 96Tests
EUR 521

Porcine LIF ELISA Kit
EPL0014 96Tests
EUR 521

Human LIF ELISA Kit
EHL0014 96Tests
EUR 521

Chicken LIF ELISA Kit
ECKL0014 96Tests
EUR 521

Canine LIF ELISA Kit
ECL0014 96Tests
EUR 521

Bovine LIF ELISA Kit
EBL0014 96Tests
EUR 521

Goat LIF ELISA Kit
EGTL0014 96Tests
EUR 521

Polyclonal LIF Antibody (Internal)
APR02876G 0.05mg
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Internal). This antibody is tested and proven to work in the following applications:

Polyclonal LIF Antibody (Center)
APR05828G 0.1ml
EUR 484
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human LIF (Center). This antibody is tested and proven to work in the following applications:

Human LIF shRNA Plasmid
20-abx952690
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Human LIF ELISA Kit
ELA-E0085h 96 Tests
EUR 824

LIF ELISA KIT|Human
EF000330 96 Tests
EUR 689

Human LIF ELISA kit
55R-2054 96 tests
EUR 712
Description: ELISA Kit for detection of LIF in the research laboratory

Human LIF ELISA kit
55R-IB49639 96 wells
EUR 1178
Description: ELISA kit for the detection of LIF in the research laboratory

Mouse Leukemia inhibitory factor, LIF ELISA kit
CSB-E04652m-24T 1 plate of 24 wells
EUR 165
Description: Quantitativesandwich ELISA kit for measuring Mouse Leukemia inhibitory factor, LIF in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.
However, the administration of urologic sufferers throughout the COVID-19 pandemic is carried out in Europa on a excessive commonplace. Therefor the danger of secondary hurt to our sufferers is anticipated to be reasonably minimal in the long term.